Article
Washington - Treatment of vitiligo has advanced significantly recently, although older therapies still retain an important place in the management of this therapeutically challenging disease, says Pearl E. Grimes, M.D.
Dupilumab Reduces Levels of Immunoglobulin E in Pediatric Patients with Moderate-to-Severe AD
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Understanding and Treating Pediatric AD Inside and Out
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Reviewing Complex Cases: Topicals for Pediatric AD
Study Finds Propranolol Initiation for Infantile Hemangiomas Safe with Less Monitoring